Pharmacogenomics of Xenobiotic Metabolizing Enzymes in South American Populations

Filho, Mário Bernardo; Albano, Rodolpho Mattos; Rossini, Ana; Ribeiro Pinto, Luis Felipe
March 2006
Current Pharmacogenomics;Mar2006, Vol. 4 Issue 1, p9
Academic Journal
The toxicity that can result from the exposure to numerous xenobiotics can vary greatly for each individual. This is mainly due to differences in the activity of xenobiotic metabolizing enzymes (XME) that participate in the disposal of toxic xenobiotics from the human body. The genes that encode XMEs present a variety of polymorphisms that occur in the promoter or coding regions, resulting in differences in the amount or in the catalytic activities of the enzymes. Human populations differ regarding the frequency of alleles and haplotypes that are present in a given geographic region. Genetic background and ancestry are the main reasons for such variability. South America, due to an extensive colonization period, is populated by descendents of Amerindians, Africans and Europeans. The admixtures that happened in each country, however, vary according to historical and geographical conditions. Brazil, for example, has one of the world's most admixed populations with genetic contributions from several tribes of Amerindians, many still existent, from Africans, and from various waves of European immigrants. In this review we will discuss the frequency of genetic polymorphisms of XMEs, particularly Cytochrome P450s and Glutathione S-transferases, found in different populations of South American countries. The genetic background and degree of population admixture of each country is taken under consideration in a discussion of the difficulties generated by enzyme polymorphisms in the treatment of individuals within such populations.


Related Articles

  • Polymorphisms of selected Xenobiotic Genes contribute to the development of Papillary Thyroid Cancer susceptibility in Middle Eastern population. Siraj, Abdul K.; Ibrahim, Muna; Al-Rasheed, Maha; Abubaker, Jehad; Bu, Rong; Siddiqui, Shakaib U; Al-Dayel, Fouad; Al-Sanea, Osama; Al-Nuaim, Abdulrahman; Uddin, Shahab; Al-Kuraya, Khawla // BMC Medical Genetics;2008, Vol. 9, Special section p1 

    Background: The xenobiotic enzyme system that enables us to detoxify carcinogens exhibits identifiable genetic polymorphisms that are highly race specific. We hypothesized that polymorphisms of these genes may be associated with risk of thyroid cancer. To evaluate the role of genetic...

  • The Dynamic Epigenome and its Implications in Toxicology.  // Toxicological Sciences;Nov2007, Vol. 100 Issue 1, p7 

    The epigenome serves as an interface between the dynamic environment and the inherited static genome. The epigenome is comprised of chromatin and a covalent modification of DNA by methylation. The epigenome is sculpted during development to shape the diversity of gene expression programs in the...

  • Human aryl hydrocarbon receptor nuclear translocator gene (ARNT) D/N511 polymorphism. Cao, Henian; Hegele, Robert A. // Journal of Human Genetics;2000, Vol. 45 Issue 2, p92 

    Abstract We found a novel A to C change in codon 511 of the ARNT gene, which predicted the substitution of Asn (AAC) for Asp (GAC) at this position. Amplification using mismatched primers allowed the ARNT D/N511 polymorphism to be detected by digestion with endonuclease TthlllI. The frequency of...

  • Structure, Function and Polymorphism of Human Cytosolic Sulfotransferases. Li, Yong; Lindsay, Julian; Wang, Lin-Lin; Zhou, Shu-Feng // Current Drug Metabolism;Feb2008, Vol. 9 Issue 2, p99 

    The sulfotransferase (SULTs) catalyzes the sulfonation of a multitude of xenobiotics, hormones and neurotransmitters. This review has summarised the SULT family in detail, the structure of the twelve known enzymes, in their four known groups (SULT1, SULT2, SULT4, and SULT6) and the substrates...

  • Pharmacogenomics of Arylamine N-acetyltransferase. Mushtaq, Adeel; Anderton, Matthew; Cornish, Valerie // Current Pharmacogenomics;Sep2004, Vol. 2 Issue 3, p219 

    The arylamine N-acetyltransferases (NATs) are a unique family of enzymes that catalyse the transfer of an acetyl group from acetyl CoA to the terminal nitrogen of hydrazine and arylamine xenobiotics. They have well characterised roles in drug detoxification and carcinogen activation and NAT...

  • Biomedical Aspects of Metabolic Portraiture. Piruzyan, L. A.; Sukhanov, V. A.; Kalinina, E. V.; Saprin, A. N. // Doklady Biochemistry & Biophysics;Mar/Apr2001, Vol. 377 Issue 1-6, p72 

    Discusses a research on the biomedical aspects of metabolic portraiture. Types of xenobiotic metabolism and detoxification enzymes (XMDE); Disturbance that may be caused by polymorphism of XMDE; Selection of interstrain donor-recipient pairs.

  • Polymorphisms of Genes Encoding Phase I Enzymes in Mexican Americans - An Ethnic Comparison Study. Huai-Rong Luo; Yu-Jui Yvonne Wan // Current Pharmacogenomics;Dec2006, Vol. 4 Issue 4, p345 

    The inter-individual and inter-ethnic variations in phase I enzyme activity is largely attributed to gene poly-morphisms. The distribution and clinical consequences of these variations have been extensively studied in Africans, Asians, and Caucasians. However, information is still lacking...

  • Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity. Iwai, Masaru; Maruo, Yoshihiro; Ito, Masaki; Yamamoto, Kazuo; Sato, Hiroshi; Takeuchi, Yoshihiro // Journal of Human Genetics;2004, Vol. 49 Issue 3, p123 

    Human UDP-glucuronosyltransferase (UGT) is a part of a major excretion pathway for endobiotics and xenobiotics. The UGT family of genes is highly polymorphic, and our aim is to describe novel polymorphisms at the UGT1A3 locus and determine how they alter substrate metabolism and drug reactions....

  • Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary history. Sabbagh, Audrey; Langaney, André; Darlu, Pierre; Gérard, Nathalie; Krishnamoorthy, Rajagopal; Poloni, Estella S. // BMC Genetics;2008, Vol. 9, Special section p1 

    Background: The N-acetyltransferase 2 (NAT2) gene plays a crucial role in the metabolism of many drugs and xenobiotics. As it represents a likely target of population-specific selection pressures, we fully sequenced the NAT2 coding region in 97 Mandenka individuals from Senegal, and compared...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics